A detailed history of Masters Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Masters Capital Management LLC holds 200,000 shares of NVCR stock, worth $6.42 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$6.42 Million
% of portfolio
0.26%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Masters Capital Management LLC Portfolio

Follow Masters Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.